Dec. 17, 2014, 4:57 PM
- A top Chinese government official says the country has approved Syngenta’s (NYSE:SYT) genetically modified Agrisure Viptera corn, one year after China began rejecting shipments of grain it said contained traces of the unapproved trait, according to U.S. Agriculture Secretary Tom Vilsack.
- Chinese Vice Premier Wang Yang said imports of the MIR 162 corn had been approved by China's Ministry of Agriculture, Vilsack says, adding that the ministry also approved imports of biotech soybeans developed by DuPont Pioneer (NYSE:DD) and Bayer CropScience (OTCPK:BAYZF, OTCPK:BAYRY).
- The import approvals do not represent a loosening of China's long regulatory review process for GMO crops, Vilsack says.
Dec. 10, 2014, 9:21 AM
- DuPont (NYSE:DD) and Denki Kagaku Kogyo have signed a definitive agreement to sell DuPont Neoprene polychloroprene to Denka Performance Elastomer, a new joint venture company owned 70% by Denki and 30% by Mitsui (OTCPK:MITSY).
- Neoprene, a synthetic rubber used for many chemical and weather-resistant products such as wet suits and orthopedic braces, was invented by Dupont 83 years ago.
- Dupont's sale comes after a considerable amount of activist investor to break itself up.
Nov. 22, 2014, 8:25 AM
- Harvard Business School's Bill George is troubled by the trend of activist investors shifting their wrath to some of America’s best companies, which he says may net nice profits in the short term but places the competitiveness of America’s great global companies at risk.
- An example is Amgen (NASDAQ:AMGN), whose stock has gained 185% in the past five years, but Dan Loeb still wants to split the company; George says this would destroy a productive innovator by taking away the cash it needs to develop new drugs and fuel growth.
- PepsiCo’s (NYSE:PEP) 52% increase in three years is double that of Coca-Cola, yet Nelson Peltz is agitating to split the company in two, as he did with Kraft - which has struggled, as has its Mondelez spinout.
- Peltz also is trying to break up DuPont (NYSE:DD) even though the stock has climbed 250% since Ellen Kullman became CEO in 2009; a disjointed conglomerate without a clear strategy, DuPont's stock had slipped 62% since 2000.
- Bill Ackman successfully partnered to put Allergan (NYSE:AGN) in play, which resulted in a sale, but George says the deal was unnecessary for a stock that had gained 2,400% since David E.I. Pyott became CEO in 1998.
- In each case, George says leaders were forced to focus on saving their companies instead of winning global competitive battles, creating great products and building new businesses.
Nov. 16, 2014, 5:44 AM
- Four workers died and a fifth was hospitalized on Saturday due to a chemical leak at a DuPont (NYSE:DD) plant near Houston.
- The chemical, methyl mercaptan, is a liquid when contained, but becomes a gas when it is released and mixes with oxygen.
- "Our focus at the moment is solely on the employees and the family members," says spokesman Aaron Woods. "But as we move past that we will begin a full investigation to understand what went wrong and what we need to do to prevent this from ever happening again."
Oct. 29, 2014, 2:48 PM
- Bayer (OTCPK:BAYZF, OTCPK:BAYRY) says its crop science unit agrees to acquire certain crop protection and land-management assets from DuPont (DD -1.7%) for an unspecified amount.
- The deal will enable Bayer to offer a broad range of products for weed control for farming, and will provide access to the growing forestry and range and pasture business segments in North America.
- DuPont will continue to sell its land management products outside of the five countries where the assets are located: the U.S., Canada, Mexico, Australia and New Zealand.
Oct. 28, 2014, 2:39 PM
- DuPont (DD +0.3%) CEO Ellen Kullman defends the company's diverse portfolio of businesses, pointing out the "competitive advantages" in developing seeds for farmers, plastics for car makers and a host of other products.
- "There is a lot of power in being able to deliver greater capability to [customers] than in being very narrow," Kullman says in her first public comments on the campaign by activist investor Nelson Peltz to break the company in two.
- "Our current capital structure provides us with important financial flexibility we need to pursue strategic growth opportunities in light of regional and highly seasonal agricultural cash flows," the CEO said in the company's earnings conference call.
- Kullman also says DuPont and Peltz are aligned in focusing on cutting costs, citing $2B in expense reductions during the past five years with plans to cut another $1B by 2020.
- Earlier: More on DuPont's Q3 results
Oct. 28, 2014, 7:09 AM
- Net income of $433M vs. $285M in the same quarter a year ago. Operating earnings per share of $0.54 vs. $0.45 per share last year.
- Operating earnings by segment: Agriculture +11%; Electronics & Communications -3%; Industrial Biosciences +4%; Nutrition & Health +23%; Performance Chemicals -5%; Performance Materials +1%; Safety & Protection +18%; Other +22%.
- The company backed its full-year operating earnings outlook of $4.00-$4.10 per share and expects its Q4 operating EPS to grow about 20% from $0.59 per share in the year-earlier period.
- Q3 results
Oct. 28, 2014, 6:01 AM
Oct. 27, 2014, 5:30 PM
- ACI, AET, AGCO, AIXG, ALR, AME, AMTD, AN, AXE, BP, CAS, CIT, CMI, CNC, CNX, COH, CPLA, CRY, CVLT, CYNO, DD, DIN, ECL, ENTG, FCX, FDP, FLWS, FMER, GLPI, GLW, HCA, HMC, HOT, HRS, ICON, IIVI, IPGP, LH, MDSO, MLM, MMC, MSM, MSO, MWV, NBL, NCI, NVS, PCAR, PCG, PES, PFE, PH, POR, RDWR, SAIA, SAVE, SCHN, SCOR, SHW, SIRI, SNCR, ST, SYRG, TECH, TKR, TRW, TTS, TWI, UBS, UTHR, VDSI, VRTS, VSH, WAB, WHR, XYL
Oct. 23, 2014, 11:23 AM
Oct. 21, 2014, 10:51 AM
- Honeywell (HON +2.1%) and DuPont (DD +1.4%) were sent a statement of objections by EU regulators for violating antitrust rules over a global refrigerant for car air conditioners.
- "The cooperation they entered into in 2010...may have limited its (the refrigerant's) availability and technical development, in breach of EU antitrust rules," the European Commission said in a statement.
- The car-coolant (R-1234yf) is the only chemical that currently meets new EU standards on greenhouse-gas emissions.
- Responding to the claim, Thierry F.J. Vanlancker, President of DuPont Chemicals & Fluoroproducts, says "DuPont has complied at all times with applicable laws...and we plan to defend vigorously against the Commission's allegations and preliminary conclusions. We will fight this every step of the way, as it has no basis in law or fact."
Oct. 8, 2014, 8:27 AM
- Despite criticism from activist investor Nelson Peltz, DuPont (NYSE:DD) says a $500M bet on producing ethanol from corn crop waste will pay off as demand for the renewable fuel increases.
- Peltz previously smeared the cellulosic ethanol plant as an example of the company's "speculative and expensive corporate science projects" that have "destroyed shareholder value." The Iowa facility will be completed in the coming months.
- "This plant will make money," says William Feehery, president of the industrial biosciences unit. "We put a lot of time and R&D money into this."
Sep. 18, 2014, 10:00 AM
Sep. 17, 2014, 9:10 AM
- DuPont (NYSE:DD) responds to Trian Fund Management's call for a breakup of the company, saying it had engaged in a "constructive dialogue" with the activist investor.
- DuPont's board says it is intent on executing on a plan that includes cutting costs by $1B, separating its performance chemicals business and buying back $5B worth of shares; cites shareholder returns of 220% vs. 144% for the S&P 500 since year-end 2008.
- DD +3.3% premarket.
Sep. 17, 2014, 4:26 AM
- Activist investor Trian Fund Management is seeking public support to force DuPont (NYSE:DD) to break itself up, after more than a year of unsuccessful private efforts.
- Trian says Dupont's overly complex corporate structure is a large weight for the company's seven business lines, and makes it difficult for investors and the company to assess their prospects.
- As it launches its new campaign, Trian says its plan would cut annual costs by $2B-$4B.
Sep. 16, 2014, 7:17 AM
DD vs. ETF Alternatives
E I du Pont de Nemours & Company is a science and engineering company that offers products and patents applications for agriculture, nutrition, electronics and communications, safety and protection, home and construction, transportation and apparel.
Other News & PR